Keep abreast of the latest news and trends in your industry. Browse through 7 million articles from over 1,500 periodicals.
Issue Date:
09/01/2002
In This Issue
|
1-7 (of 7) related articles
Items per page
| |
|
1. NANOSPHERE/TAKARO BIO FORM DEVELOP/DISTRIBUTE ALLIANCE.
Nanosphere, Inc., Northbrook, Ill., a privately held nanotechnology-based life sciences company, has signed a letter of intent to form a development and distribution alliance with ... (PREMIUM PERIODICAL ARTICLE)
2. GENEFORMATICS/DE NOVO FORM DRUG DISCOVERY COLLABORATION.
GeneFormatics Inc., San Diego, Calif., and De Novo Pharmaceuticals, Cambridge, U.K., have formed a collaborative drug discovery program to elucidate inhibitors of matrix metalloproteinases, specifically ... (PREMIUM PERIODICAL ARTICLE)
3. MERIDIAN BEGINS DISTRIBUTION OF RAPID TEST FOR STOMACH ULCERS.
Meridian Bioscience, Inc., (Nasdaq:VIVO), Cincinnati, has begun international distribution of its patent protected ImmunoCard Stat! HpSA rapid test for Helicobacter pylori bacteria, the primary cause ... (PREMIUM PERIODICAL ARTICLE)
4. FDA GRANTS "APPROVABLE" STATUS FOR TEVA'S ANDA FOR GABAPENTIN.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), Jerusalem, Israel, has announced that the U.S. Food and Drug Administration has granted an "approvable" status for the company's ... (PREMIUM PERIODICAL ARTICLE)
5. MEDICURE GETS U.S. PATENT NOTICE OF ALLOWANCE FOR THERAPEUDICS.
Medicure Inc. (TSX:MPH), Winnipeg, Manitoba, a cardiovascular company, has received a Notice of Allowance from the U.S. Patent Office for a composition of matter patent ... (PREMIUM PERIODICAL ARTICLE)
6. GRAFFINITY SIGNS COLLABORATION AGREEMENT WITH ELI LILLY.
Graffinity Pharmaceuticals, Heidelberg, Germany, has entered into an agreement with Eli Lilly and company (NYSE: LLY). Graffinity will utilize its novel chemical genomics technology, and ... (PREMIUM PERIODICAL ARTICLE)
7. BAYER TO ACQUIRE VISIBLE GENETICS FOR $61.4 MILLION IN CASH.
Bayer Corporation, Diagnostics Division (NYSE: BAY), Tarrytown, N.Y. and Visible Genetics Inc. (VGI) (NASDAQ: VGIN), Toronto, have signed a definitive agreement providing for Bayer Diagnostics ... (PREMIUM PERIODICAL ARTICLE) | |
|
1-7 (of 7) related articles
Items per page
1-7 (of 7) related articles
|
2006
2005
2004
2003
2002
2001
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
